Disclosure Of First-Time Adoption [Text Block]

Pharming Group N.V. - Filing #2154299

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
218,781,000 USD
265,262,000 USD
2,057,000 USD
478,431,000 USD
7,669,000 USD
204,638,000 USD
8,737,000 USD
462,297,000 USD
256,431,000 USD
7,509,000 USD
273,167,000 USD
3,400,000 USD
192,916,000 USD
455,254,000 USD
7,429,000 USD
Comprehensive income
3,445,000 USD
7,103,000 USD
10,548,000 USD
USD
USD
USD
11,054,000 USD
2,620,000 USD
13,674,000 USD
USD
Profit (loss)
10,548,000 USD
USD
10,548,000 USD
USD
USD
USD
USD
13,674,000 USD
13,674,000 USD
USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.